Brief: Madrigal Pharmaceuticals Q1 EPS USD -7.38
07/05/2024 12:00
May 07 (Reuters) - Madrigal Pharmaceuticals Q1 net income USD -147.541 million. * Q1 operating income USD -152.037 million * Q1 operating expenses USD 152.037 million
Recent news on Madrigal Pharmaceuticals
See all newsBrief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule
Madrigal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Madrigal Pharmaceuticals Q2 revenue rises 71% on Rezdiffra demand
U.S. RESEARCH ROUNDUP-Boeing, Coca-Cola, PayPal
Brief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)